Simultaneous Emergence of Entecavir Resistance Mutations in a Nucleoside-Naive Chronic Hepatitis B Patient

Publisher： Karger

E-ISSN： 1423-0100|55|5|380-384

ISSN： 0300-5526

Source： Intervirology, Vol.55, Iss.5, 2012-04, pp. : 380-384

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adefovir and Lamivudine Combination Therapy in Patients with Entecavir-Resistant Chronic Hepatitis B: Antiviral Responses and Evolution of Mutations

By  

Intervirology, Vol. 57, Iss. 5, 2014-06 ,pp. : 239-247

Karger

Access to resources Recommend Favorite

A review of entecavir in the treatment of chronic hepatitis B infection

By Rivkin Anastasia  

Current Medical Research and Opinion, Vol. 21, Iss. 11, 2005-11 ,pp. : 1845-1856

Informa Healthcare

Access to resources Recommend Favorite

Long-Term Efficacy of Entecavir Plus Adefovir Combination Therapy versus Entecavir Monotherapy in Adefovir Refractory Chronic Hepatitis B Patients with Prior Lamivudine Resistance

By  

Intervirology, Vol. 57, Iss. 1, 2013-08 ,pp. : 8-16

Karger

Access to resources Recommend Favorite

Clinical Course of Virologic Breakthrough after Emergence of YMDD Mutations in HBeAg-Positive Chronic Hepatitis B

By  

Intervirology, Vol. 51, Iss. 4, 2008-11 ,pp. : 293-298

Karger

Access to resources Recommend Favorite

4′‐modified nucleoside analogs: Potent inhibitors active against entecavir‐resistant hepatitis B virus

By  

HEPATOLOGY, Vol. 270-9139, Iss. 4, 2015-10 ,pp. : 1024-1036

John Wiley & Sons Inc

Access to resources Recommend Favorite